Trial Profile
Single-arm Phase II Study of Maintenance Therapy With Aflibercept After First-line Treatment With FOLFIRI Plus Aflibercept in Metastatic Colorectal Cancer Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms AMALTHEA
- 23 Oct 2017 Status changed from active, no longer recruiting to completed.
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress
- 12 May 2016 Status changed from recruiting to active, no longer recruiting.